Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine

作者在写作过程中使用生成式人工智能或AI辅助技术时，仅可用于提升可读性和语言表达，且须在人工监督与控制下进行，并仔细审查和编辑AI生成的内容，因为AI可能产生看似权威但错误、不完整或有偏见的结果。 模型中文摘要

The below guidance only refers to the writing process, and not to the use of AI tools to analyze and draw insights from data as part of the research process. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human o…

通讯作者须代表全体作者披露可能与他人或组织存在、可能不当影响其工作的财务和个人关系，包括雇佣、顾问、持股、酬金、有偿专家证言、专利申请/注册及资助等潜在利益冲突，所有作者（包括无利益冲突者）都应向通讯作者提供相关信息。 模型中文摘要

Corresponding authors, on behalf of all the authors of a submission, must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other …

出版伦理方面的信息请参见该期刊的“出版伦理”页面。 模型中文摘要

Please see our information on Ethics in publishing.

文章被接受后，作者将被要求签署许可协议；开放获取文章的第三方再使用权限取决于作者选择的用户许可。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.Responsible sharingFind out how you can share your rese…

文章处理费（APC）的相关信息（包括折扣和减免）请参见作者APC指南和开放获取页面；作为ISAKOS会员的通讯作者可享受文章出版费20%的折扣；通讯作者在初次投稿后不可更改（除非主编决定的极少数特殊情况）。 模型中文摘要

For more information on Article Processing Charges, including discounts and waivers, see our Author APC Guide and Open Access Page. Corresponding Authors who are ISAKOS members will receive a 20% discount on the article publication charge. To learn about becoming a member, please visit: ISAKOS Membership Application. PLEASE NOTE: corresponding authors cannot be changed after the initial submission…

该期刊采用单盲同行评审，稿件通常至少送交两名独立专家审稿人以评估科学质量，编辑对接受或拒稿拥有最终决定权，且编辑不参与涉及自身或亲属、同事或其有利益关系的论文的决策。 模型中文摘要

This journal operates using a single-blind review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written thems…

预印本可随时在任何地方共享，符合Elsevier的共享政策；在预印本服务器上分享预印本不计作先前发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

如果临床试验结果以少于500字的结构化摘要或表格形式发布在同一注册库中，JISAKOS不将其视为先前发表。 模型中文摘要

JISAKOS does not consider results posted in the same clinical trials registry in which primary registration resides to be a prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table.